PRECLINICAL STUDY: CLINICAL RESEARCH
Dependence of Platelet Thrombus Stability on Sustained Glycoprotein IIb/IIIa Activation Through Adenosine 5'-Diphosphate Receptor Stimulation and Cyclic Calcium Signaling
Shinya Goto, MD*,*,
Noriko Tamura, MS*,
Hideyuki Ishida, MD and
Zaverio M. Ruggeri, MD
* Departments of Medicine
Basic Medicine, Tokai University School of Medicine, Kanagawa, Japan
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California
Manuscript received February 13, 2005;
revised manuscript received July 24, 2005,
accepted August 1, 2005.
* Reprint requests and correspondence: Dr. Shinya Goto, Department of Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan (Email: shinichi{at}is.icc.u-tokai.ac.jp).
OBJECTIVES: We sought to evaluate the mechanisms that support the stability of platelet aggregates on a thrombogenic surface exposed to flowing blood.
BACKGROUND: Activation of the membrane glycoprotein (GP) IIb/IIIamediated in part through the P2Y1 and P2Y12 adenosine 5'-diphosphate (ADP) receptorsis necessary for platelet aggregation. Platelets in growing thrombi exhibit cyclic calcium signal, suggesting that sustained activation may be required for thrombus stability.
METHODS: Blood was perfused over type I collagen fibrils at the wall shear rate of 1,500 s1. Three-dimensional visualization of platelet thrombi was obtained in real time with confocal microscopy. The intracytoplasmic Ca2+ concentration ([Ca2+]i) was measured in fluo-3AMloaded platelets.
RESULTS: The height of platelet thrombi in control blood was 13.5 ± 3.3 µm after 6 min, and increased to 16.3 ± 4.5 µm (n = 8) after an additional 6 min. In contrast, the height was reduced to 5.4 ± 2.2 and 3.3 ± 1.3 µm, respectively (p < 0.01, n = 8), when the blood used in the second 6-min perfusion contained a P2Y1 (MRS2179) or P2Y12 (AR-C69931MX) inhibitor. The [Ca2+]i of platelets within forming thrombi oscillated between 212 ± 38 nmol/l and 924 ± 458 nmol/l, with cycles lasting 4.2 ± 2.8 s that were inhibited completely by AR-C69931MX and partially by MRS2179. Accordingly, thrombi became unstable upon perfusion of blood containing the Ca2+ channel blocker, lanthanum chloride. Flow cytometric studies demonstrated that AR-C69931MX, MRS2179, and lanthanum chloride reduced monoclonal antibody PAC-1 binding to platelets, indicating a decrease of membrane-expressed activated GP IIb/IIIa.
CONCLUSIONS: Continuous P2Y1 and P2Y12 stimulation resulting in cyclic [Ca2+]i oscillations is required for maintaining the activation of GP IIb/IIIa needed for thrombus stability in flowing blood.
|
Abbreviations and Acronyms
| | ADP = adenosine diphosphate | | [Ca2+]i = intracytoplasmic Ca2+ concentration | | FITC = fluorescein isothiocyanate | | GP = glycoprotein | | PPP = platelet-poor plasma | | PRP = platelet-rich plasma | | VWF = von Willebrand factor |
|
This article has been cited by other articles:

|
 |

|
 |
 
S. Nisar, M. E. Daly, A. B. Federici, A. Artoni, A. D. Mumford, S. P. Watson, and S. J. Mundell
An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets
Blood,
November 17, 2011;
118(20):
5641 - 5651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Andre, T. Morooka, D. Sim, K. Abe, C. Lowell, N. Nanda, S. Delaney, G. Siu, Y. Yan, S. Hollenbach, et al.
Critical role for Syk in responses to vascular injury
Blood,
November 3, 2011;
118(18):
5000 - 5010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. I. Simon and S. A. Parikh
Hunting for the "Sweet Spot" in P2Y12 Receptor Blockade
J. Am. Coll. Cardiol.,
October 6, 2009;
54(15):
1447 - 1449.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nishikii, K. Eto, N. Tamura, K. Hattori, B. Heissig, T. Kanaji, A. Sawaguchi, S. Goto, J. Ware, and H. Nakauchi
Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells
J. Exp. Med.,
August 4, 2008;
205(8):
1917 - 1927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Auger and S. P. Watson
Dynamic Tyrosine Kinase-Regulated Signaling and Actin Polymerisation Mediate Aggregate Stability Under Shear
Arterioscler Thromb Vasc Biol,
August 1, 2008;
28(8):
1499 - 1504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Angiolillo, E. Bernardo, M. Sabate, P. Jimenez-Quevedo, M. A. Costa, J. Palazuelos, R. Hernandez-Antolin, R. Moreno, J. Escaned, F. Alfonso, et al.
Impact of Platelet Reactivity on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
J. Am. Coll. Cardiol.,
October 16, 2007;
50(16):
1541 - 1547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jirouskova, J. K. Jaiswal, and B. S. Coller
Ligand density dramatically affects integrin {alpha}IIb{beta}3-mediated platelet signaling and spreading
Blood,
June 15, 2007;
109(12):
5260 - 5269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. F. Brass
Thrombus formation: stability matters
Blood,
November 1, 2006;
108(9):
2883 - 2884.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. E. M. Cosemans, I. C. A. Munnix, R. Wetzker, R. Heller, S. P. Jackson, and J. W. M. Heemskerk
Continuous signaling via PI3K isoforms beta and {gamma} is required for platelet ADP receptor function in dynamic thrombus stabilization
Blood,
November 1, 2006;
108(9):
3045 - 3052.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|